- Clinical, biochemical and psychometric findings with the new MAO-A-inhibitors moclobemide and brofaromine in patients with major depressive disorder. Laux, G., Classen, W., Sofic, E., Becker, T., Riederer, P., Lesch, K.P., Struck, M., Beckmann, H. J. Neural Transm. Suppl. (1990)